Authors:
Easterbrook, PJ
Newson, R
Ives, N
Pereira, S
Moyle, G
Gazzard, BG
Citation: Pj. Easterbrook et al., Comparison of virologic, immunologic, and clinical response to five different initial protease inhibitor-containing and nevirapine-containing regimens, J ACQ IMM D, 27(4), 2001, pp. 350-364
Authors:
Torti, C
Gilleece, Y
Hertogs, K
Gazzard, BG
Pozniak, AL
Citation: C. Torti et al., R211K and L214F ho not invariably confer high level phenotypic resistance to thymidine analogs in zidovndine-naive patients with M184V, J ACQ IMM D, 26(5), 2001, pp. 514-515
Authors:
Moore, DAJ
Benepal, T
Portsmouth, S
Gill, J
Gazzard, BG
Citation: Daj. Moore et al., Etiology and natural history of neutropenia in human immunodeficiency virus disease: A prospective study, CLIN INF D, 32(3), 2001, pp. 469-475
Authors:
Pearson, IC
Baker, R
Sullivan, AK
Nelson, MR
Gazzard, BG
Citation: Ic. Pearson et al., Meningococcal infection in patients with the human immunodeficiency virus and acquired immunodeficency syndrome, INT J STD A, 12(6), 2001, pp. 410-411
Authors:
Walsh, JC
Horne, R
Dalton, M
Burgess, AP
Gazzard, BG
Citation: Jc. Walsh et al., Reasons for non-adherence to antiretroviral therapy: patients' perspectives provide evidence of multiple causes, AIDS CARE, 13(6), 2001, pp. 709-720
Authors:
Gibbons, CL
Ong, CSL
Miao, Y
Casemore, DP
Gazzard, BG
Awad-El-Kariem, FM
Citation: Cl. Gibbons et al., PCR-ELISA: a new simplified tool for tracing the source of cryptosporidiosis in HIV-positive patients, PARASIT RES, 87(12), 2001, pp. 1031-1034
Citation: Js. Herman et al., Incidence and risk factors for the development of indinavir-associated renal complications, J ANTIMICRO, 48(3), 2001, pp. 355-360
Authors:
Torti, C
Pozniak, A
Nelson, M
Hertogs, K
Gazzard, BG
Citation: C. Torti et al., Distribution of K103N and/or Y181CHIV-1 mutations by exposure to zidovudine and non-nucleoside reverse transcriptase inhibitors, J ANTIMICRO, 48(1), 2001, pp. 113-116
Authors:
Churchill, DR
Slade, PM
Youle, M
Gazzard, BG
Wcber, JN
Citation: Dr. Churchill et al., A phase I/II study of the safety and activity of a microsphere formulationof KNI-272 in patients with HIV-1 infection, J ANTIMICRO, 47(3), 2001, pp. 353-355
Citation: Gj. Moyle et Bg. Gazzard, Differing reverse transcriptase mutation patterns in individuals experiencing viral rebound on first-line regimens with stavudine/didanosine and stavudine/lamivudine, AIDS, 15(6), 2001, pp. 799-800
Authors:
Moyle, GJ
Lloyd, M
Reynolds, B
Baldwin, C
Mandalia, S
Gazzard, BG
Citation: Gj. Moyle et al., Dietary advice with or without pravastatin for the management of hypercholesterolaemia associated with protease inhibitor therapy, AIDS, 15(12), 2001, pp. 1503-1508
Citation: Nj. Ives et al., The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART) in a London clinic, J INFECTION, 42(2), 2001, pp. 134-139
Authors:
Miao, YM
Awad-El-Kariem, FM
Franzen, C
Ellis, DS
Muller, A
Counihan, HM
Hayes, PJ
Gazzard, BG
Citation: Ym. Miao et al., Eradication of cryptosporidia and microsporidia following successful antiretroviral therapy, J ACQ IMM D, 25(2), 2000, pp. 124-129
Authors:
Matthews, GV
Moyle, GJ
Mandalia, S
Bower, M
Nelson, M
Gazzard, BG
Citation: Gv. Matthews et al., Absence of association between individual thymidine analogues or nonnucleoside analogues and lipid abnormalities in HIV-1-infected persons on initialtherapy, J ACQ IMM D, 24(4), 2000, pp. 310-315
Authors:
Thornton, S
Troop, M
Burgess, AP
Button, J
Goodall, R
Flynn, R
Gazzard, BG
Catalan, J
Easterbrook, PJ
Citation: S. Thornton et al., The relationship of psychological variables and disease progression among long-term HIV-infected men, INT J STD A, 11(11), 2000, pp. 734-742
Authors:
Al-Shahi, R
Bower, M
Nelson, MR
Gazzard, BG
Citation: R. Al-shahi et al., Cerebrospinal fluid Epstein-Barr virus detection preceding HIV-associated primary central nervous system lymphoma by 17 months, J NEUROL, 247(6), 2000, pp. 471-472
Citation: Gj. Moyle et al., Frequency of multinucleoside analogue-resistant genotypes observed during antiretroviral therapy, AIDS, 14(9), 2000, pp. 1292-1293
Authors:
Moyle, GJ
Wilkins, E
Leen, C
Cheesbrough, A
Reynolds, B
Gazzard, BG
Citation: Gj. Moyle et al., Salvage therapy with abacavir plus efavirenz or nevirapine in HIV-1-infected persons with previous nucleoside analogue and protease inhibitor use, AIDS, 14(10), 2000, pp. 1453-1454
Authors:
Hannan, MM
Azadian, BS
Gazzard, BG
Hawkins, DA
Hoffman, PN
Citation: Mm. Hannan et al., Hospital infection control in an era of HIV infection and multi-drug resistant tuberculosis, J HOSP INF, 44(1), 2000, pp. 5-11
Authors:
Neild, PJ
Nijran, KS
Yazaki, E
Evans, DF
Wingate, DL
Jewkes, R
Gazzard, BG
Citation: Pj. Neild et al., Delayed gastric emptying in human immunodeficiency virus infection - Correlation with symptoms, autonomic function, and intestinal motility, DIG DIS SCI, 45(8), 2000, pp. 1491-1499
Authors:
Carpenter, CCJ
Cooper, DA
Fischl, MA
Gatell, JM
Gazzard, BG
Hammer, SM
Hirsch, MS
Jacobsen, DM
Katzenstein, DA
Montaner, JSG
Richman, DD
Saag, MS
Schechter, M
Schooley, RT
Vella, S
Yeni, PG
Volberding, PA
Citation: Ccj. Carpenter et al., Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel, J AM MED A, 283(3), 2000, pp. 381-390